August 15, 2013 – FDA Drug Safety Communication issued regarding a potential increased risk of peripheral neuropathy with fluoroquinolone antibiotics.
August 15, 2013 – FDA Drug Safety Communication issued regarding a potential increased risk of peripheral neuropathy with fluoroquinolone antibiotics.